Barclays’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $1.01M | Sell |
|
|||||
|
2024
Q3 | $345K | Buy |
|
|||||
|
2024
Q2 | $151K | Sell |
|
|||||
|
2024
Q1 | $240K | Sell |
|
|||||
|
2023
Q4 | $408K | Buy |
|
|||||
|
2023
Q3 | $109K | Buy |
|
|||||
|
2023
Q2 | $57K | Sell |
|
|||||
|
2023
Q1 | $316K | Buy |
|
|||||
|
2022
Q4 | $308K | Buy |
|
|||||
|
2022
Q3 | $111K | Buy |
|
|||||
|
2022
Q2 | $76K | Sell |
|
|||||
|
2022
Q1 | $152K | Buy |
|